세계의 보디 컨투어링 디바이스 시장 예측(-2029년) : 제품별, 용도별, 연령층별, 성별, 최종사용자별, 지역별

The body contouring devices market is projected to reach USD 3.00 Billion by 2029 from USD 1.74 Billion in 2024, at a CAGR of 11.4% during the forecast period. Market expansion is propelled by factors such as the growing utilization of non-invasive body contouring devices, increase in the advertisement of aesthetic procedures on social media and easily accessible clinics andbeauty centers for these procedures. Conversely, significant market consolidation among key players and the need for substantial capital investments pose notable obstacles to market growth.

"Non-invasive segment accounted for the highest CAGR."

By product, the market is primarily segmented into non-invasive and invasive. The non-invasive segment accounted for the highest growth rate of the body contouring devices in 2023. The substantial increase in market growth can be primarily attributed to the extensive utilization of both non-invasive and minimally invasive body contouring devices. Furthermore, advancements in the technology of application such as fat reduction and body tonning instruments and the growing demand for aesthetic and plastic surgeries are driving the expansion of this sector.

"The fat reduction segment accounted for the market share in the body contouring devices market, byapplication, during the forecast period."

Byapplication, the market is primarily segmented into body toning and sculpting, fat reduction, cellulite treatment and skin tighteing. In 2023, non-robotic surgery accounted for the highest share of this market. The main factors propelling the growth of the market are the cost effective procedures for fat reduction, increase use of technologies like radiofrequency and lasers that provides least risk risingmiddle aged population. Additionally, surgeons preference of fat reduction devices over the slow weight loss process, contributing to their continued prominence in the market.

"Between 35 to 50 years segment accounted for the highest growth rate."

By age group , the market is primarily segmented into between 35to 50 years, above 50 years and below 35 years . The between 30 to 50 years segment accounted for the highest growth rate of the body contouring devices age group market in 2023. The primary drivers of growth in this market are increase in obese population among the middle age population, increase competition among this age group population to look aesthetic and increase in advertisement of the body contouring procedures over social media.

"Female segment accounted for the largest market share."

By gender , the market is primarily segmented into female and male . The female segment accounted for the highest share of the body contouring devices gender market in 2023. Easy accessibility of the body contouring devices and procedures, increased adoption of the body changes by female for aesthetic appearance and improved technologically advanced procedures with lowest downtime are the major reasons attributing to the largest share of the gender body contouring devices market.

"Specialty clinics segment accounted for the highest share."

By end user, the market is primarily segmented into hospitals, specialty clinics and medical spas and beauty centers. The specialty clinics segment accounted for a larger share of the body contouring devices market in 2023. This can be credited to the significant volume of non-invasive surgical procedures carried out inspecialty clinics, facilitated by the presence of highly skilled healthcare professionals.

"Asia Pacific: The fastest-growing region in body contouring devices market."

The global body contouring devices market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa and GCC Countries. Various factors are contributing to the growth of the market in the Asia-Pacific (APAC) region, including escalating healthcare expenditure, increase in medical tourism in the regions like China, India, Vietnam, rising per capita income, expansion of private-sector healthcare facilities into rural areas across several APAC nations and the existence of high-growth markets in the region. Moreover, the advantageous regulatory landscape and low costs in this region are anticipated to further drive market expansion.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (42%), Europe (31%), Asia- Pacific (20%), Latin America (4%), Middle East & Africa(2%) and GCC Countries (1%)

Lists of Companies Profiled in the Report:

• Abbvie, Inc. (US)
• Cutera (US)
• Bausch Health Companies Inc. (Canada)
• InMode Ltd. (Israel)
• Venus Concept (Canada)
• ENDYMED Medical (US)
• Cynosure Lutronic (US)
• Lumenis BE Ltd. (Israel)
• Alma Lasers (Israel)
• Candela Corporation (US)
• BTL Aesthetics Ltd. (UK)
• MicroAire Surgical Instruments LLC (US)
• Fotona (Slovenia)
• Nouvag AG (Switzerland)
• Erchonia Corporation (US)
• Konmison (China)
• Skinnovation Pvt. Ltd. (India)
• 3D Aesthetics (UK)
• Zimmer MedizinSystems Gmbh (Germany)
• Rohrer Aesthetics (US)
• Skin Aesthetics (India)
• SharpLight Technologies Inc. (Israel)
• Sebbin (France)
• Deka M.E.L.A. S.R.L. (Italy)
• INDIBA (Spain)

Research Coverage

This research report categorizes the body contouring devices market by product, application, age group, gender, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the body contouring devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview; key strategies; product launch, approval, acquisition, merger and recent developments associated with the body contouring devices market. Competitive analysis of upcoming startups in the body contouring devices market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall body contouring devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (Growing adoption of minimally invasive and noninvasive aesthetic procedures), restraints (High cost of treatment and lack of reimbursement), opportunities (Improving healthcare infrastructure in emerging markets), and challenges (Stringent regulatory compliance and safety standards) influencing the growth of the body contouring devices market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the body contouring devices market
• Market Development: Comprehensive information about lucrative markets - the report analyses the body contouring devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the body contouring devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Abbvie, Inc. (US), Cutera (US), Bausch Health Companies Inc. (Canada), InMode Ltd. (Israel), Venus Concept (Canada) among others in body contouring devices market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS & EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 BODY CONTOURING DEVICES MARKET
  • 1.4.2 YEARS CONSIDERED
  • 1.4.3 CURRENCY CONSIDERED
• 1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 ASSUMPTIONS & LIMITATIONS
  • 2.5.1 GROWTH RATE ASSUMPTIONS
  • 2.5.2 LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 BODY CONTOURING DEVICES MARKET OVERVIEW
• 4.2 BODY CONTOURING DEVICES MARKET SHARE, BY TYPE, 2024 VS. 2029
• 4.3 BODY CONTOURING DEVICES MARKET SHARE, BY APPLICATION, 2024 VS. 2029
• 4.4 BODY CONTOURING DEVICES MARKET SHARE, BY AGE GROUP, 2024 VS. 2029
• 4.5 BODY CONTOURING DEVICES MARKET SHARE, BY GENDER, 2024 VS. 2029
• 4.6 BODY CONTOURING DEVICES MARKET SHARE, BY END USER, 2024 VS. 2029
• 4.7 BODY CONTOURING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing adoption of minimally invasive and non-invasive aesthetic procedures
    • 5.2.1.2 Increasing awareness and acceptance of body contouring
    • 5.2.1.3 Increasing demand for aesthetic treatments among men
    • 5.2.1.4 Technological advancements
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of treatment and lack of reimbursement
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Improving healthcare infrastructure in emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Stringent regulatory compliance and safety standards
    • 5.2.4.2 Social and cultural barriers in emerging economies
• 5.3 PRICING ANALYSIS
  • 5.3.1 INDICATIVE PRICING MODEL ANALYSIS OF MARKET PLAYERS
  • 5.3.2 AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION
• 5.4 PATENT ANALYSIS
  • 5.4.1 LIST OF MAJOR PATENTS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 TRADE ANALYSIS
  • 5.7.1 TRADE ANALYSIS FOR LASER AESTHETIC DEVICES
• 5.8 ECOSYSTEM ANALYSIS
  • 5.8.1 BODY CONTOURING DEVICES MARKET: ROLE IN ECOSYSTEM
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 THREAT OF NEW ENTRANTS
  • 5.9.2 THREAT OF SUBSTITUTES
  • 5.9.3 BARGAINING POWER OF BUYERS
  • 5.9.4 BARGAINING POWER OF SUPPLIERS
  • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.10 REGULATORY LANDSCAPE
  • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10.2 REGULATORY ANALYSIS
    • 5.10.2.1 North America
      • 5.10.2.1.1 US
      • 5.10.2.1.2 Canada
    • 5.10.2.2 Europe
    • 5.10.2.3 Asia Pacific
      • 5.10.2.3.1 China
      • 5.10.2.3.2 Japan
      • 5.10.2.3.3 India
    • 5.10.2.4 Latin America
      • 5.10.2.4.1 Brazil
      • 5.10.2.4.2 Mexico
    • 5.10.2.5 Middle East
• 5.11 TECHNOLOGY ANALYSIS
  • 5.11.1 KEY TECHNOLOGIES
    • 5.11.1.1 Cryolipolysis
    • 5.11.1.2 Radiofrequency (RF)
    • 5.11.1.3 High-intensity-focused Ultrasound (HIFU)
  • 5.11.2 COMPLEMENTARY TECHNOLOGIES
    • 5.11.2.1 Laser-assisted devices
    • 5.11.2.2 Implants
  • 5.11.3 ADJACENT TECHNOLOGIES
    • 5.11.3.1 Body sculpting rollers
    • 5.11.3.2 Electrostimulation devices
• 5.12 KEY CONFERENCES & EVENTS IN 2024-2025
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.13.1 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 IMPACT OF AI ON BODY CONTOURING DEVICES MARKET

6 BODY CONTOURING DEVICES MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 NON-INVASIVE DEVICES
  • 6.2.1 RADIOFREQUENCY (RF) DEVICES
    • 6.2.1.1 Ability to deliver noticeable results with minimal downtime to drive market growth
  • 6.2.2 CRYOLIPOLYSIS/FAT FREEZING DEVICES
    • 6.2.2.1 Risk associated with fat freezing to challenge market growth
  • 6.2.3 HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) DEVICES
    • 6.2.3.1 Minimal downtime of HIFU devices to support adoption
  • 6.2.4 LOW-LEVEL LASER THERAPY (LLLT) DEVICES
    • 6.2.4.1 Increased patient safety and quick results to support market growth
  • 6.2.5 OTHER NON-INVASIVE DEVICES
• 6.3 INVASIVE DEVICES
  • 6.3.1 LIPOSUCTION DEVICES
    • 6.3.1.1 Increasing obese population to drive growth
  • 6.3.2 LASER-ASSISTED DEVICES
    • 6.3.2.1 Shift towards minimally invasive aesthetic treatments to drive growth
  • 6.3.3 IMPLANTS/FILLERS
    • 6.3.3.1 Rising demand for cosmetic implants to fuel growth

7 BODY CONTOURING DEVICES MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 FAT REDUCTION
  • 7.2.1 INCREASING NUMBER OF NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES TO PROPEL MARKET GROWTH
• 7.3 SKIN TIGHTENING
  • 7.3.1 INTRODUCTION OF CUTTING-EDGE DEVICES TO FUEL UPTAKE
• 7.4 BODY TONING & SCULPTING
  • 7.4.1 INCREASED CONSUMER DESIRE FOR ENHANCED BODY AESTHETICS TO DRIVE MARKET GROWTH
• 7.5 CELLULITE TREATMENT
  • 7.5.1 ADVANTAGES ASSOCIATED WITH ROBOTIC-ASSISTED SURGERY TO BOOST MARKET GROWTH

8 BODY CONTOURING DEVICES MARKET, BY AGE GROUP

• 8.1 INTRODUCTION
• 8.2 BETWEEN 35 TO 50 YEARS
  • 8.2.1 GROWING INTEREST IN MAINTAINING YOUTHFUL APPEARANCE TO DRIVE MARKET GROWTH
• 8.3 ABOVE 50 YEARS
  • 8.3.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN ACCEPTANCE OF COSMETIC PROCEDURES TO BOOST MARKET
• 8.4 BELOW 35 YEARS
  • 8.4.1 INCREASING NUMBER OF CUSTOMIZABLE TREATMENT PLANS TO FAVOR MARKET GROWTH

9 BODY CONTOURING DEVICES MARKET, BY GENDER

• 9.1 INTRODUCTION
• 9.2 WOMEN
  • 9.2.1 INCREASED AWARENESS AND ACCESSIBILITY OF BODY CONTOURING PROCEDURES TO DRIVE MARKET GROWTH
• 9.3 MEN
  • 9.3.1 INCREASING ACCEPTANCE OF AESTHETIC PROCEDURES AMONG MEN TO BOOST UPTAKE

10 BODY CONTOURING DEVICES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 SPECIALTY CLINICS
  • 10.2.1 OPERATIONAL ENHANCEMENTS, COMBINED WITH TARGETED MARKETING STRATEGIES, TO PROPEL MARKET
• 10.3 MEDICAL SPAS & BEAUTY CENTERS
  • 10.3.1 AVAILABILITY OF MEDICAL TREATMENT IN COMFORTABLE AND RELAXING SETTINGS TO AID MARKET GROWTH
• 10.4 HOSPITALS
  • 10.4.1 GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES IN HOSPITALS TO SUPPORT MARKET GROWTH

11 BODY CONTOURING DEVICES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Increased demand for aesthetic procedures to drive market growth
  • 11.2.3 CANADA
    • 11.2.3.1 Rapid increase in geriatric population and increased awareness about non-invasive body contouring procedures to boost market
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Rising disposable incomes to boost use of body contouring devices
  • 11.3.3 UK
    • 11.3.3.1 Reduced stigma for body contouring procedures to drive market growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Improved standard of living and growing disposable income to support market growth
  • 11.3.5 ITALY
    • 11.3.5.1 Increasing number of plastic surgeons to favor market growth
  • 11.3.6 SPAIN
    • 11.3.6.1 Increasing demand for cosmetic procedures and rising availability of safe minimally invasive technology to fuel growth
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Growing availability of body contouring surgery to drive market
  • 11.4.3 JAPAN
    • 11.4.3.1 Increasing number of plastic surgeons to propel market growth in Japan
  • 11.4.4 INDIA
    • 11.4.4.1 Increasing disposable incomes to drive market growth in India
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Growing focus on medical tourism to drive market growth
  • 11.5.3 MEXICO
    • 11.5.3.1 Growing volume of surgical procedures to aid market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 IMPLEMENTATION OF FAVORABLE INITIATIVES TO BOOST MARKET
  • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 11.7 GCC COUNTRIES
  • 11.7.1 HIGHER DISPOSABLE INCOMES TO SUPPORT MARKET GROWTH
  • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BODY CONTOURING DEVICES MARKET
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 LIST OF EVALUATED VENDORS
  • 12.5.2 STARS
  • 12.5.3 EMERGING LEADERS
  • 12.5.4 PERVASIVE PLAYERS
  • 12.5.5 PARTICIPANTS
  • 12.5.6 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.6.1 Company footprint
    • 12.5.6.2 Type footprint
    • 12.5.6.3 Application footprint
    • 12.5.6.4 Region footprint
• 12.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/PRODUCT COMPARISON
  • 12.8.1 ABBVIE, INC.
  • 12.8.2 CYNOSURE LUTRONIC
  • 12.8.3 CUTERA
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES & APPROVALS
  • 12.9.2 DEALS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 ABBVIE, INC.
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches & approvals
      • 13.1.1.3.2 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 INMODE LTD.
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 MnM view
      • 13.1.2.3.1 Right to win
      • 13.1.2.3.2 Strategic choices
      • 13.1.2.3.3 Weaknesses & competitive threats
  • 13.1.3 BAUSCH HEALTH COMPANIES INC.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product approvals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 CYNOSURE LUTRONIC
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 MnM view
      • 13.1.4.3.1 Right to win
      • 13.1.4.3.2 Strategic choices
      • 13.1.4.3.3 Weaknesses & competitive threats
  • 13.1.5 CUTERA, INC.
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 VENUS CONCEPT
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches & approvals
  • 13.1.7 ENDYMED MEDICAL
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
  • 13.1.8 LUMENIS BE LTD.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
  • 13.1.9 ALMA LASERS
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
  • 13.1.10 CANDELA CORPORATION
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product launches
• 13.2 OTHER PLAYERS
  • 13.2.1 BTL AESTHETICS LTD.
  • 13.2.2 MICROAIRE SURGICAL INSTRUMENTS, LLC
  • 13.2.3 FOTONA
  • 13.2.4 NOUVAG AG
  • 13.2.5 ERCHONIA CORPORATION
  • 13.2.6 KONMISON
  • 13.2.7 SKINNOVATION PVT. LTD.
  • 13.2.8 3D AESTHETICS
  • 13.2.9 ZIMMER MEDIZINSYSTEME GMBH
  • 13.2.10 ROHRER AESTHETICS
  • 13.2.11 SKIN AESTHETICS
  • 13.2.12 SHARPLIGHT TECHNOLOGIES INC.
  • 13.2.13 SEBBIN
  • 13.2.14 DEKA M.E.L.A. S.R.L.
  • 13.2.15 INDIBA

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS